• Fri, August 12, 2022
Geulah Livshits Maintained (CABA) at Strong Buy with Decreased Target to $13 on, Aug 12th, 2022
Geulah Livshits of Chardan Capital, Maintained "Cabaletta Bio, Inc." (CABA) at Strong Buy with Decreased Target from $17 to $13 on, Aug 12th, 2022.
Geulah has made no other calls on CABA in the last 4 months.
There is 1 other peer that has a rating on CABA. Out of the 1 peers that are also analyzing CABA, 0 agree with Geulah's Rating of Hold.
This is the rating of the analyst that currently disagrees with Geulah
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $10 on, Wednesday, May 25th, 2022
Like: 👍
